REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
16/03/2026
Voltar para busca
Dado oficial do USPTO
QUANOVATE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
QUANOVATE
ST13
US500000087703576Classe
9, 10, 44
Pedido
87703576
Registro
6295564
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
53
Atualização mais recente
17/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 10, 44
Data de depósito
30/11/2017
Data de registro
16/03/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/03/2021
Última transação
17/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
13/12/2018
Primeiro uso no comércio
13/12/2018
Código do desenho
4
Tipo de titular
03
Localização do titular
Pleasanton, CA, US
Examinador
KEAN, AMY C
Unidade examinadora
M30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Quanovate Tech Inc.
Representantes
Cher Sauer Tantalum Trademarks
Classificação técnica
Classes Nice
Classe 9Classe 10Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
softwarefor use with medical patient monitoring equipment for data storage and management; software for recordingtracking and predicting menstrual cyclesovulationfertility and related women's health issues; medical and telemedicine software applications for data storage and data sharing between health providers and product users; downloadable mobile application for monitoring a woman's menstrual cycleovulationfertility and pregnancy
Classe 10
diagnostic apparatus for medical use in connection with reproductive medicinefor recognizing physiological and other changes during the menstrual cycle as well as pregnancy; medical diagnostic test kits consisting primarily of probesbuffers and reagents for use in monitoring fetal chronic and infectious disease; diagnostic test kits consisting primarily of probesbuffers and reagents for use in identifying and measuring key biomarkers in fetal specimens; medical apparatusfetal and maternal vital sign and physical distress monitors; diagnostic test kits consisting primarily of probesbuffers and reagents for animal use in monitoring chronic or infectious disease and fertility status; diagnostic test kits consisting primarily of probesbuffers and reagents for use in identifying and measuring key biomarkers in animal specimens
Classe 44
medical testing for diagnostic or treatment purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
53 publicações encontradas
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
25/06/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
25/06/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
25/06/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
25/06/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
16/03/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/02/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/02/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
10/02/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/02/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
10/02/2021
SNEA
SU-EXAMINER'S AMENDMENT WRITTEN
10/02/2021
RDX3
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
30/07/2020
RDX1
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
30/07/2020
RRDX
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
30/07/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/07/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/07/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
23/07/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/02/2020
GNFR
FINAL REFUSAL E-MAILED
06/02/2020
CNFR
SU - FINAL REFUSAL - WRITTEN
06/02/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/12/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/12/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/12/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
27/06/2019
GNRT
NON-FINAL ACTION E-MAILED
27/06/2019
CNRT
SU - NON-FINAL ACTION - WRITTEN
27/06/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
18/06/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
17/06/2019
EX2G
SOU EXTENSION 2 GRANTED
17/06/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
17/06/2019
IUAF
USE AMENDMENT FILED
11/06/2019
EXT2
SOU EXTENSION 2 FILED
11/06/2019
EEXT
SOU TEAS EXTENSION RECEIVED
11/06/2019
EISU
TEAS STATEMENT OF USE RECEIVED
11/06/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
15/12/2018
EX1G
SOU EXTENSION 1 GRANTED
13/12/2018
EXT1
SOU EXTENSION 1 FILED
13/12/2018
EEXT
SOU TEAS EXTENSION RECEIVED
13/12/2018
DOCK
ASSIGNED TO EXAMINER
12/12/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
26/06/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/05/2018
PUBO
PUBLISHED FOR OPPOSITION
01/05/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/04/2018
ALIE
ASSIGNED TO LIE
26/03/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
19/03/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
19/03/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
19/03/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
19/03/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
19/03/2018
DOCK
ASSIGNED TO EXAMINER
13/03/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/12/2017
NWAP
NEW APPLICATION ENTERED
04/12/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace QUANOVATE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.